Yiheng Capital Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$503K Hold
21,126
0.22% 23
2025
Q4
$586K Sell
21,126
-47,932
-69% -$1.22M 0.12% 22
2025
Q3
$1.68M Hold
69,058
0.25% 24
2025
Q2
$1.17M Hold
69,058
0.11% 22
2025
Q1
$1.35M Sell
69,058
-357,044
-84% -$9.35M 0.13% 21
2024
Q4
$10.6M Sell
426,102
-337,658
-44% -$8.62M 0.41% 16
2024
Q3
$18.7M Sell
763,760
-81,740
-10% -$2.11M 0.96% 12
2024
Q2
$19.8M Hold
845,500
1.6% 16
2024
Q1
$27.9M Hold
845,500
1.55% 12
2023
Q4
$23M Buy
845,500
+285,000
+51% +$7.08M 1.33% 15
2023
Q3
$13.5M Buy
560,500
+96,700
+21% +$2.59M 0.69% 23
2023
Q2
$14.8M Hold
463,800
0.8% 19
2023
Q1
$14.2M Hold
463,800
0.56% 22
2022
Q4
$18.1M Buy
463,800
+100,000
+27% +$4.48M 0.8% 19
2022
Q3
$17.3M Hold
363,800
1.07% 19
2022
Q2
$14.1M Buy
363,800
+340,400
+1,455% +$13.5M 0.81% 26
2022
Q1
$1.34M Buy
+23,400
New +$1.53M 0.06% 32

Other funds holding BEAM